End-of-day quote
Taipei Exchange
06:00:00 2024-06-03 pm EDT
|
5-day change
|
1st Jan Change
|
41.7
TWD
|
-0.71%
|
|
-0.12%
|
+7.20%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
4,520
|
4,823
|
4,173
|
3,153
|
3,140
|
3,374
|
Enterprise Value (EV)
1 |
4,027
|
5,158
|
4,247
|
5,334
|
6,293
|
6,114
|
P/E ratio
|
18.4
x
|
19.6
x
|
21
x
|
26.3
x
|
-10.1
x
|
23.4
x
|
Yield
|
3.45%
|
3.24%
|
3.12%
|
2.34%
|
-
|
2.57%
|
Capitalization / Revenue
|
0.82
x
|
0.79
x
|
0.78
x
|
0.66
x
|
0.66
x
|
0.73
x
|
EV / Revenue
|
0.73
x
|
0.85
x
|
0.79
x
|
1.12
x
|
1.33
x
|
1.33
x
|
EV / EBITDA
|
8.77
x
|
10.7
x
|
15.2
x
|
92.2
x
|
220
x
|
25.9
x
|
EV / FCF
|
-452
x
|
-277
x
|
14.3
x
|
-3.66
x
|
-9.13
x
|
41.5
x
|
FCF Yield
|
-0.22%
|
-0.36%
|
6.99%
|
-27.3%
|
-10.9%
|
2.41%
|
Price to Book
|
1.38
x
|
1.51
x
|
1.3
x
|
1.07
x
|
1.07
x
|
0.96
x
|
Nbr of stocks (in thousands)
|
86,747
|
86,747
|
86,747
|
86,747
|
86,747
|
86,747
|
Reference price
2 |
52.10
|
55.60
|
48.10
|
36.35
|
36.20
|
38.90
|
Announcement Date
|
3/13/19
|
3/2/20
|
3/2/21
|
3/2/22
|
3/7/23
|
3/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
5,510
|
6,093
|
5,384
|
4,767
|
4,730
|
4,592
|
EBITDA
1 |
459.3
|
484
|
278.7
|
57.87
|
28.61
|
235.8
|
EBIT
1 |
355.3
|
336.4
|
117.7
|
-98.15
|
-149.5
|
70.61
|
Operating Margin
|
6.45%
|
5.52%
|
2.19%
|
-2.06%
|
-3.16%
|
1.54%
|
Earnings before Tax (EBT)
1 |
369.7
|
365
|
249.9
|
84.77
|
-328.1
|
256.3
|
Net income
1 |
246.7
|
247.7
|
199.3
|
120.2
|
-310.8
|
143.9
|
Net margin
|
4.48%
|
4.06%
|
3.7%
|
2.52%
|
-6.57%
|
3.13%
|
EPS
2 |
2.830
|
2.840
|
2.290
|
1.380
|
-3.583
|
1.659
|
Free Cash Flow
1 |
-8.919
|
-18.61
|
297
|
-1,457
|
-689
|
147.3
|
FCF margin
|
-0.16%
|
-0.31%
|
5.52%
|
-30.57%
|
-14.56%
|
3.21%
|
FCF Conversion (EBITDA)
|
-
|
-
|
106.57%
|
-
|
-
|
62.5%
|
FCF Conversion (Net income)
|
-
|
-
|
149.01%
|
-
|
-
|
102.36%
|
Dividend per Share
2 |
1.800
|
1.800
|
1.500
|
0.8500
|
-
|
1.000
|
Announcement Date
|
3/13/19
|
3/2/20
|
3/2/21
|
3/2/22
|
3/7/23
|
3/1/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
335
|
74.4
|
2,181
|
3,153
|
2,739
|
Net Cash position
1 |
492
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
0.6922
x
|
0.2668
x
|
37.69
x
|
110.2
x
|
11.62
x
|
Free Cash Flow
1 |
-8.92
|
-18.6
|
297
|
-1,457
|
-689
|
147
|
ROE (net income / shareholders' equity)
|
3.58%
|
3.44%
|
2.77%
|
2.02%
|
-8.57%
|
4.45%
|
ROA (Net income/ Total Assets)
|
3.2%
|
2.78%
|
0.92%
|
-0.7%
|
-0.94%
|
0.42%
|
Assets
1 |
7,718
|
8,901
|
21,718
|
-17,204
|
32,980
|
34,643
|
Book Value Per Share
2 |
37.80
|
36.80
|
37.00
|
33.90
|
33.80
|
40.50
|
Cash Flow per Share
2 |
20.20
|
20.20
|
24.50
|
22.60
|
20.80
|
20.00
|
Capex
1 |
202
|
128
|
233
|
1,563
|
639
|
99.4
|
Capex / Sales
|
3.66%
|
2.11%
|
4.32%
|
32.78%
|
13.51%
|
2.16%
|
Announcement Date
|
3/13/19
|
3/2/20
|
3/2/21
|
3/2/22
|
3/7/23
|
3/1/24
|
|
1st Jan change
|
Capi.
|
---|
| +7.20% | 113M | | +4.94% | 7.74B | | +2.93% | 5.92B | | -5.18% | 3.77B | | -11.51% | 3.52B | | -12.06% | 1.23B | | -28.83% | 1.04B | | +15.98% | 988M | | -8.82% | 929M | | -14.37% | 823M |
Special Foods & Wellbeing Products
|